aldosterone
Showing 26 - 50 of 1,257
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism, Adrenal Tumors Trial in Singapore
Recruiting
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +2 more
- 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
-
Singapore, Singapore
- +6 more
Oct 26, 2023
Primary Aldosteronism Trial (ablation of aldosterone secreting adenoma, Unilateral adrenalectomy)
Not yet recruiting
- Primary Aldosteronism
- ablation of aldosterone secreting adenoma
- Unilateral adrenalectomy
- (no location specified)
May 31, 2022
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)
Recruiting
- Heart Failure
- Hyperkalemia
- Sodium zirconium cyclosilicate
- Placebo
-
Gothenburg, SwedenSahlgrenska University Hospital-Ostra Hospital
Sep 20, 2021
Heart Rate Variability on Endothelial Function Via RAAS
Not yet recruiting
- Obstructive Sleep Apnea
-
Kuching, Sarawak, MalaysiaUniversiti Malaysia Sarawak
Jan 30, 2022
Endothelial Dysfunction, Insulin Resistance Trial in Odense (Eplerenone)
Completed
- Endothelial Dysfunction
- Insulin Resistance
-
Odense, DenmarkCardiovascular and Renal Research
May 28, 2021
Healthy Volunteers Trial in Boston (Placebo, Fludrocortisone, Eplerenone)
Completed
- Healthy Volunteers
- Placebo
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 4, 2021
Healthy Subjects Trial in Boston (Simvastatin, Pravastatin, Placebo)
Completed
- Healthy Subjects
- Simvastatin
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital- 221 Longwood Avenue
May 3, 2021
Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)
Recruiting
- Angiotensin/Renin/Aldosterone Hypertension
- +2 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Aug 16, 2022
Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Dapagliflozin
- +2 more
-
Porto, Portugal
- +1 more
Jan 12, 2023
Outcome of Patients With Primary Aldosteronism
Recruiting
- Primary Aldosteronism
- +8 more
- Unilateral adrenalectomy in patients with unilateral disease
-
Singapore, SingaporeChangi General Hospital
Aug 10, 2021
Glucose Metabolism in Aldosterone-Producing Adenomas
Completed
- Primary Aldosteronism
- Adrenalectomy
- mineralocorticoid receptor antagonist
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 28, 2021
Postural Tachycardia Syndrome Trial in Nashville (Cosyntropin administration)
Completed
- Postural Tachycardia Syndrome
- Cosyntropin administration
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 4, 2022
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Nodular Hyperplasia, Adrenal Cushing
Completed
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +4 more
-
Uppsala, SwedenUppsala University Hospital
Apr 29, 2022
Myocardial Infarction Trial in Vandoeuvre les Nancy (blood sample, MRI, echocardiography)
Completed
- Myocardial Infarction
- blood sample
- +6 more
-
Vandoeuvre les Nancy, Meurthe Et Moselle, FranceNancy Brabois university hospital
Mar 22, 2021
Adrenal and Other Endocrine Tumors in Patients With Sudden Death
Recruiting
- Primary Aldosteronism
- +3 more
- Adrenal aldosterone synthase (CYP11B2) staining
- +2 more
-
Helsinki, FinlandEndocrinology, Helsinki University Hospital and University of He
Jul 8, 2022
Metabolic Syndrome Trial in Nashville (Low Salt diet plus Placebo tablet, Low Sodium diet plus Salt tablet, Epleronone)
Completed
- Metabolic Syndrome
- Low Salt diet plus Placebo tablet
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 30, 2020
Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,
Completed
- Idiopathic Membranous Nephropathy
- symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
- experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
-
Paris, FranceDepartment of Nephrology , Tenon hospital - APHP
Oct 18, 2021
Hypertension Trial in Boston (Lisinopril, Atenolol)
Withdrawn
- Hypertension
- Lisinopril, Atenolol
-
Boston, MassachusettsBrigham and Women's Hospital
Apr 7, 2021
Acute Decompensated Heart Failure Trial in Gainesville (Change of treatment plan)
Completed
- Acute Decompensated Heart Failure
- Change of treatment plan
-
Gainesville, FloridaUF Health at the University of Florida
Apr 21, 2021
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin
Not yet recruiting
- Hyperkalemia
- No intervention
- (no location specified)
Aug 10, 2020
Treatment of Resistant Hypertension: Cohort Study
Recruiting
- Resistant Hypertension
- Add-on therapy
-
Belgrade, Serbia
- +11 more
Oct 21, 2021
Salt Taste Threshold in Patients Being Investigated for Primary
Unknown status
- Hyperaldosteronism; Primary
- +3 more
- adrenalectomy
- Aldosterone Antagonist
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 15, 2020
Primary Aldosteronism Due to Aldosterone Producing Adenoma Trial in Zhengzhou (Renal Sympathetic Denervation)
Completed
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- Renal Sympathetic Denervation
-
Zhengzhou, Henan, ChinaZhengzhou university People's Hospital
Oct 30, 2020